GlassScriptPhysician profile
Ryan A Mccune
NPI 1871007187
$2,362.78
in general payments reported to CMS, 2019-2025
20 companies · $697 in 2025
The $697 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $342 · 2023: $567 · 2024: $756 · 2025: $697.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,020.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,020.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $598.81 | 2022-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $410.65 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $253.23 | 2022-2025 | Jardiance |
| Pfizer INC. | $251.41 | 2022-2025 | |
| Amgen INC. | $237.65 | 2022-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $119.63 | 2023-2025 | Verquvo, Keytruda |
| Novo Nordisk INC | $103.37 | 2025 | Wegovy |
| United Therapeutics Corporation | $72.26 | 2022-2025 | Tyvaso, Tyvaso |
| Smith+Nephew, INC. | $49.29 | 2025 | Renasys Go V2 Home, Pico 14, Renasys Touch |
| Lexicon Pharmaceuticals, INC. | $38.77 | 2023-2024 | Inpefa |
| Janssen Pharmaceuticals, INC | $36.14 | 2023 | Xarelto |
| Kiniksa Pharmaceuticals International, Plc | $33.95 | 2024 | Arcalyst |
| Abiomed | $30.12 | 2025 | |
| Boston Scientific Corporation | $27.25 | 2024 | Watchman Access System |
| Bayer Healthcare Pharmaceuticals INC. | $21.39 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $19.36 | 2024 | Preveleak |
| Impulse Dynamics (USA) INC. | $17.22 | 2025 | Optimizer |
| Medtronic, INC. | $15.58 | 2024 | Plasmablade(Tm) |
| Genzyme Corporation | $14.25 | 2023 | |
| Kiniksa Pharmaceuticals, LTD. | $12.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Mccune listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.